Erratum to “When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study” [Bull. Cancer 109 (2022) 916–24](S0007455122001916)(10.1016/j.bulcan.2022.04.014)

Anne Pascale Meert, Anne Claire Toffart, Muriel Picard, Paul Jaubert, Aude Gibelin, Philippe Bauer, Djamel Mokart, Andry Van De Louw, Stefan Hatzl, Gabriel Moreno-Gonzales, Gaelle Rousseau-Bussac, Fabrice Bruneel, Luca Montini, Anne Sophie Moreau, Dorothée Carpentier, Amelie Seguin, Pleun Hemelaar, Elie Azoulay, Virginie Lemiale

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original PDF version of this article published in the September 2022 issue 109/9 of Bulletin du Cancer, the abstract and keywords did not match the rest of the article. The XML version available online was correct. The PDF file has been updated and the version currently online is now correct. We apologize for the inconvenience to the authors and the readers.

Original languageEnglish (US)
Pages (from-to)467-468
Number of pages2
JournalBulletin du Cancer
Volume110
Issue number4
DOIs
StatePublished - Apr 2023

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum to “When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study” [Bull. Cancer 109 (2022) 916–24](S0007455122001916)(10.1016/j.bulcan.2022.04.014)'. Together they form a unique fingerprint.

Cite this